User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group

Primary tabs

Benamer, HTS Patterson, J Grosset, DG Booij, J de Bruin, K Ries, V

OBJECTIVE: To evaluate whether visual assessment of [I-123]-FP-CIT (DaTSCAN(TM), Nycomed Amersham, pie) single photon emission computerized tomography (SPECT) images can differentiate between parkinsonism and essential tremor (ET). METHODS: [I-123]-FP-CIT SPECT imaging was conducted in a six-center study of 158 patients with a clinical diagnosis of parkinsonism compared with 27 ET cases and 35 healthy volunteers. Striatal uptake of the radioligand was graded normal or abnormal, and abnormal images were further graded to three levels of severity. An institutional read whereby each center visually assessed the images blinded to the clinical data and a consensus blinded read by a panel of five was undertaken. RESULTS: The institutional reading scored 154 of 158 cases of parkinsonism abnormal, all 27 cases of ET as normal, and 34 of 35 healthy volunteers as normal compared with the consensus blinded read scoring 150 cases of parkinsonism as abnormal, 25 ET cases as normal, and 33 healthy volunteers as normal. Sensitivity for the clinical diagnosis of parkinsonism was 97% and specificity for ET was 100% for the institutional read, whereas sensitivity was 95% and specificity 93% for the consensus blinded read. Semiquantitative analysis of specific: nonspecific caudate and putamen uptake were consistent with the results of visual inspection. CONCLUSION: Visual assessment of [I-123]-FP-CIT SPECT images is an easily applied diagnostic test which is helpful in the differential diagnosis of tremor disorders and in confirming a clinical diagnosis of a hypokinetic-rigid syndrome.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2000
Language Anglais
Journal information "Movement Disorders" - Vol. 15, no. 3, p. 503-510 (2000)
Peer reviewed yes
Publisher Lippincott Williams & Wilkins (Philadelphia)
issn 0885-3185
e-issn 1531-8257
Publication status Publié
Affiliation UCL
Keywords parkinsonism ; essential tremor ; [I-123]-FP-CIT ; SPECT
Links
  1. Critchley E., Clinical manifestations of essential tremor, 10.1136/jnnp.35.3.365
  2. Larsen T. Andreo, Calne Donald B., Essential Tremor : , 10.1097/00002826-198309000-00002
  3. Marshall J., OBSERVATIONS ON ESSENTIAL TREMOR, 10.1136/jnnp.25.2.122
  4. Essential tremor. An epidemiological, clinical, and genetic study [thesis]. Turku, Finland: University of Turku, 1978.
  5. Brooks D. J., Playford E. D., Ibanez V., Sawle G. V., Thompson P. D., Findley L. J., Marsden C. D., Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study, 10.1212/wnl.42.8.1554
  6. Quinn N., Fortnightly Review: Parkinsonism--recognition and differential diagnosis, 10.1136/bmj.310.6977.447
  7. Brooks David J., Functional imaging in relation to parkinsonian syndromes, 10.1016/0022-510x(93)90061-3
  8. Amara Susan G., Kuhar Michael J., Neurotransmitter Transporters: Recent Progress, 10.1146/annurev.ne.16.030193.000445
  9. Jaber Mohamed, Jones Sara, Giros Bruno, Caron Marc G, The dopamine transporter: A crucial component regulating dopamine transmission, 10.1002/mds.870120502
  10. Kaufman Marc J., Madras Bertha K., Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum, 10.1002/syn.890090107
  11. Niznik Hyman B., Fogel Evan F., Fassos Frank F., Seeman Philip, The Dopamine Transporter Is Absent in Parkinsonian Putamen and Reduced in the Caudate Nucleus, 10.1111/j.1471-4159.1991.tb02580.x
  12. Rajput A. H., Rozdilsky B., Ang L., Rajput A., Clinicopathologic observations in essential tremor: Report of six cases, 10.1212/wnl.41.9.1422
  13. Asenbaum S., Pirker W., Angelberger P., Bencsits G., Pruckmayer M., Brücke T., [ 123 I]β-CIT and SPECT in essential tremor and Parkinson's disease, 10.1007/s007020050124
  14. Laruelle Marc, Wallace Elizabeth, Seibyl John P., Baldwin Ronald M., Zea-Ponce Yolanda, Zoghbi Sami S., Neumeyer John L., Charney Dennis S., Hoffer Paul B., Innis Robert B., Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects, 10.1038/jcbfm.1994.131
  15. Booij Jan, Andringa Gerda, Rijks Leonie J.M., Vermeulen R. Jeroen, De Bruin Kora, Boer Gerard J., Janssen Anton G.M., Van Royen Eric A., [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys, 10.1002/(sici)1098-2396(199711)27:3<183::aid-syn4>3.0.co;2-9
  16. Booij Jan, Busemann Sokole Ellinor, Stabin Michael G., Janssen Anton G. M., de Bruin Kora, van Royen Eric A., Human biodistribution and dosimetry of [ 123 I]FP-CIT: a potent radioligand for imaging of dopamine transporters, 10.1007/s002590050190
  17. Booij J, Tissingh G, Boer G J, Speelman J D, Stoof J C, Janssen A G, Wolters E C, van Royen E A, [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease., 10.1136/jnnp.62.2.133
  18. Booij J., Tissingh G., Winogrodzka A., Boer G. J., Stoof J. C., Wolters E. C., van Royen E. A., Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease, 10.1007/bf01728311
  19. Tissingh, J Nucl Med, 37, 1143 (1998)
  20. Booij, J Nucl Med, 39, 1879 (1998)
  21. Gibb W R, Lees A J, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease., 10.1136/jnnp.51.6.745
  22. Definitions and behavioural classifications. In: eds. Handbook of Tremor Disorders. New York, NY: Marcel Dekker, 1995:1-5.
  23. members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: eds. Recent Developments in Parkinson's Disease. Florham Park; NJ: Macmillan Healthcare Information, 1987:153-164.
  24. Hughes A.J, Lees A.J, Stern G.M, Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes, 10.1016/0140-6736(90)91531-e
  25. D'Costa D F, Abbott R J, Pye I F, Millac P A, The apomorphine test in parkinsonian syndromes., 10.1136/jnnp.54.10.870
  26. Hughes A. J., Lees A. J., Stern G. M., Challenge tests to predict the dopaminergic response in untreated Parkinson's disease, 10.1212/wnl.41.11.1723
  27. Gasser T., Schwarz J., Arnold G., Trenkwalder C., Oertel W. H., Apomorphine Test for Dopaminergic Responsiveness in Patients With Previously Untreated Parkinson's Disease, 10.1001/archneur.1992.00530350045017
  28. Neurology, 46, 147 (1996)
  29. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R. C., Goetz C. G., Golbe L. I., Grafman J., Growdon J. H., Hallett M., Jankovic J., Quinn N. P., Tolosa E., Zee D. S., Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop, 10.1212/wnl.47.1.1
  30. Hoehn M. M., Yahr M. D., Parkinsonism: onset, progression, and mortality, 10.1212/wnl.17.5.427
  31. et al. Development of a useful [123I]-FP-CIT SPECT protocol to demonstrate the dopaminergic deficit in patients with Parkinson's disease in routine clinical studies. In: Imaging of dopamine transporters in Parkinson's disease with SPECT, chapter 5. PhD Thesis, University of Amsterdam 1998:69-91.
  32. Abi-Dargham, J Nucl Med, 37, 1129 (1996)
  33. An Atlas of the Human Brain for Computed Tomography. Stuttgart: Gustau Fister Verlag, 1978.
  34. Seibyl, J Nucl Med, 39, 1500 (1998)
  35. Hughes A J, Daniel S E, Kilford L, Lees A J, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases., 10.1136/jnnp.55.3.181
  36. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J., What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study, 10.1212/wnl.42.6.1142
  37. Research diagnostic criteria for Parkinson's disease. In: eds. Advances in Neurology. New York, NY: Raven Press, 1990;53:245-249.
  38. Brücke T., Asenbaum S., Pirker W., Djamshidian S., Wenger S., Wöber Ch., Müller Ch., Podreka I., Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECT, Advances in Research on Neurodegeneration (1997) ISBN:9783211828984 p.9-24, 10.1007/978-3-7091-6842-4_2
  39. Messa C., Volonté M. A., Fazio F., Zito F., Carpinelli A., d'Amico A., Rizzo G., Moresco R. M., Paulesu E., Franceschi M., Lucignani G., Differential distribution of striatal [ 123 I]β-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography, 10.1007/s002590050295
  40. Brooks D. J., Ibanez V., Sawle G. V., Quinn N., Lees A. J., Mathias C. J., Bannister R., Marsden C. D., Frackowiak R. S. J., Differing patterns of striatal18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy, 10.1002/ana.410280412
  41. Burn D J, Sawle G V, Brooks D J, Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data., 10.1136/jnnp.57.3.278
  42. Antonini A, Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease, 10.1093/brain/120.12.2187
Bibliographic reference Benamer, HTS ; Patterson, J ; Grosset, DG ; Booij, J ; de Bruin, K ; et. al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group. In: Movement Disorders, Vol. 15, no. 3, p. 503-510 (2000)
Permanent URL http://hdl.handle.net/2078.1/43532